SYBX
SYNLOGIC, INC.
OTC Pharmaceutical Preparations Non-accelerated filer
Smaller reporting company

Key Financials

Operating Income
$-4008000
↑ 90.2%
Revenue
$0
↓ 100.0%
Net Income
$-1005000
↑ 95.7%
Total Assets
$15.4M
↓ 22.1%
EPS (Diluted)
$-0.08
↑ 95.8%
Shareholders' Equity
$11.9M
↓ 7.0%
Total Liabilities
$3.8M
↓ 35.4%
Cash & Equivalents
$14.7M
↓ 22.2%

Recent SEC Filings

Form Type Filed Date Link
25-NSE 5/18/2026 View on SEC
10-Q 5/14/2026 View on SEC
10-K/A 4/30/2026 View on SEC
SCHEDULE 13D/A 4/6/2026 View on SEC
10-K 3/12/2026 View on SEC
8-K/A 1/29/2026 View on SEC
SCHEDULE 13G 1/23/2026 View on SEC
8-K 1/20/2026 View on SEC
8-K 12/16/2025 View on SEC
8-K 11/26/2025 View on SEC

Company Information

Field Value
Ticker SYBX
Company Name SYNLOGIC, INC.
CIK 1527599
Sector Pharmaceutical Preparations
Industry Non-accelerated filer
Smaller reporting company
Exchange OTC
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 617-659-2802